HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christina Tekle Selected Research

API 2

1/2017Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells.
2/2016Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christina Tekle Research Topics

Disease

8Neoplasms (Cancer)
01/2019 - 08/2008
4Melanoma (Melanoma, Malignant)
01/2019 - 08/2008
3Multiple Myeloma
11/2021 - 11/2019
3Neoplasm Metastasis (Metastasis)
01/2017 - 08/2008
3Breast Neoplasms (Breast Cancer)
02/2016 - 08/2008
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2010 - 04/2008
1Triple Negative Breast Neoplasms
02/2016
1Colorectal Neoplasms (Colorectal Cancer)
12/2012
1Osteosarcoma (Osteogenic Sarcoma)
08/2008
1Carcinogenesis
08/2008

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2019 - 08/2008
3Pharmaceutical PreparationsIBA
01/2019 - 06/2011
3Small Interfering RNA (siRNA)IBA
05/2012 - 08/2008
2Dacarbazine (DIC)FDA LinkGeneric
01/2019 - 01/2017
2Monoclonal AntibodiesIBA
01/2017 - 08/2008
2EverolimusFDA Link
01/2017 - 02/2016
2API 2IBA
01/2017 - 02/2016
2matrigelIBA
05/2012 - 08/2008
2Pemetrexed (MTA)FDA Link
01/2010 - 04/2008
2Biological ProductsIBA
01/2010 - 08/2008
1pomalidomideIBA
11/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2021
1isatuximabIBA
11/2021
1carfilzomibIBA
11/2020
1Lenalidomide (CC 5013)FDA Link
11/2019
1Cisplatin (Platino)FDA LinkGeneric
01/2019
1p38 Mitogen-Activated Protein KinasesIBA
01/2019
1VemurafenibIBA
01/2017
1binimetinibIBA
01/2017
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2017
1MTOR InhibitorsIBA
02/2016
1ParaffinIBA
12/2012
1Complement System Proteins (Complement)IBA
12/2012
1Tissue Inhibitor of MetalloproteinasesIBA
05/2012
1Interleukin-8 (Interleukin 8)IBA
05/2012
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
05/2012
1Matrix Metalloproteinases (MMPs)IBA
05/2012
1Paclitaxel (Taxol)FDA LinkGeneric
06/2011
1enzastaurinIBA
01/2010
1CarcinogensIBA
08/2008
1AntigensIBA
08/2008
1Fibronectins (Fibronectin)IBA
08/2008
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2008
1TunicamycinIBA
08/2008
1phorbolIBA
08/2008
1Folic Acid AntagonistsIBA
04/2008
1ErbB Receptors (EGF Receptor)IBA
04/2008
1Tyrosine Kinase InhibitorsIBA
04/2008
1Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2008

Therapy/Procedure

5Therapeutics
11/2019 - 05/2012
2Drug Therapy (Chemotherapy)
01/2019 - 01/2017